Companies & Industry »Company News»Company News Details
Company News Details

BSE   22 Sep 17 | 12:00 AM

1013.55 -18.9 (-1.83%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 500257
Face Value: N.A.

NSE   22 Sep 17 | 12:00 AM

1014.40 -16 (-1.55%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: LUPIN
Performance
1 Week : Rs 1,007.10 (0.64%)
1 Month : Rs 954.80 (6.15%)
1 Year : Rs 1,488.75 (-31.92%)
change companytradenow
Back

Lupin to launch sleep disorder drug in US

Aneesh Phadnis / Mumbai: 30 Nov 16 | 08:15 AM

Lupin is launching generic version of sleep disorder Nuvigil tablets in the US market. The brand has an annual market size of $515 million and Lupin is the third company to launch the generic version in the US.

On Tuesday Lupin announced it had received the US Food and Drug Administration department's final approval for the product and is launching the product shortly. The product was filed from the company's Goa plant which recently received clearance from the US drug regulator.

Widgets Magazine

US business contributes over 40 per cent to the company revenue. In the first half, the business grew to 78 per cent to Rs 4,186 crore on a year on year basis. The results include the contribution of drug firm Gavis which the company acquired earlier this year.

Lupin has so far launched five products in the US market in current fiscal and has received 16 product approvals in the same period.

Widgets Magazine

Sensex

Company Price Gain (%)
Wipro294.051.00
Coal India253.900.12

Messages

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine